Management of local recurrence of breast cancer

Expert Review of Anticancer Therapy

Volumn 4, Issue 2, 2004, Pages 219-226

  Easson, Alexadra M ^a   McCaready, David R ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Breast cancer; Local recurrence; Management; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN; ESTROGEN RECEPTOR; TAMOXIFEN;

ASPIRATION BIOPSY; BONE METASTASIS; BRACHYTHERAPY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CLINICAL TRIAL; FEMALE; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MAMMOGRAPHY; MASTECTOMY; PARTIAL MASTECTOMY; PUNCH BIOPSY; REVIEW;

EID: 1842639037     PISSN: 14737140     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737140.4.2.219     Document Type: Review

References (75)

1. Brinton L, Lacey J, Devesa SS. Epidemiology of breast cancer. In: Cancer of the Breast. Donegan WL, Spratt JS (Eds), Saunders, MO, USA, 111-132 (2002).
2. Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy and total mastectomy followed by irradiation. N. Engl. J. Med. 347(8), 567-575 (2002).
3. Veronesi U, Cascinelli N, Mariani L et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N. Engl. J. Med. 347(16), 1227-1232 (2002).
4. Voogd AC, Nielsen M, Peterse JL et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: Pooled results of two large European randomized trials. J. Clin. Oncol. 19(6), 1688-1697 (2001).
5. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N. Engl. J. Med. 333(22), 1444-1455 (1995).
6. Jacobson JA, Danforth DN, Cowan KH et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N. Engl. J. Med. 332(14), 907-911 (1995).
7. Fisher B, Anderson S, Bryant J et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer. N. Engl. J. Med. 347(16), 1233-1241 (2002).
8. Barros AC, Teixeira LC, Nisida AC, Pinotti M, Pinotti JA. Prognostic effects of local recurrence after conservative treatment for early infiltrating breast carcinoma. Tumori 88(5), 376-378 (2002).
9. Tsuda H, Takarabe T. Akashi-Tanaka S, Fukutomi T, Nanasawa T, Watanabe T. Evaluation of histopathological criteria for identifying node-negative breast cancer with high risk of early recurrence in the NSAS-BC protocol study. Breast Cancer 7(3), 201-209 (2000).
10. Fisher ER, Anderson S, Tan-Chiu E, Fisher B, Eaton L, Wolmark N. Fifteen-year prognostic discriminants for invasive breast carcinoma: National Surgical Adjuvant Breast and Bowel Project Protocol-06. Cancer 91(8 Suppl.), 1679-1687 (2001).
11. Arriagada R, Le MG, Contesso G, Guinebretiere JM, Rochard F, Spielmann M. Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer. Ann. Oncol. 13(9), 1404-1413 (2002).
12. Connolly JL, Boyages J, Nixon AJ et al. Predictors of breast recurrence after conservative surgery and radiation therapy for invasive breast cancer. Mod. Pathol. 11(2), 134-139 (1998).
13. Singletary SE. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am. J. Surg. 184(5), 383-393 (2002).
14. Whelan TJ, Lada BM, Laukkanen E, Perera FE, Shelley WE, Levine MN. Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Provincial Breast Disease Site Group. Cancer Prev. Control 1(3), 228-240 (1997).
15. Vicini FA. Contemporary use of brachytherapy in the treatment of breast cancer. Breast Diseases Year Book Quart. 14(1), 14-18 (2003).
16. Veronesi U, Gatti G, Luini A et al. Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery. Arch. Surg. 138(11), 1253-1256 (2003).
17. Bartelink H, Horiot JC, Poortmans P et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N. Engl. J. Med. 345(19), 1378-1387 (2001).
18. Romestaing P, Lehingue Y, Carrie C et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer: Results of a randomized clinical trial in Lyon, France. J. Clin. Oncol. 15(3), 963-968 (1997).
19. Perera F, Yu E, Engel J et al. Patterns of breast recurrence in a pilot study of brachytherapy confined to the lumpectomy site for early breast cancer with six years' minimum follow-up. Int. J. Radiat. Oncol. Biol. Phys. 57(5), 1239-1246 (2003).
20. Fisher B, Bryant J, Dignam JJ et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J. Clin. Oncol. 20(20), 4141-4149 (2002).
21. Newman LA, Buzdar AU, Singletary SE et al. A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast-conservation therapy feasibility. Ann. Surg. Oncol. 9(3), 228-234 (2002).
22. Cance WG, Carey LA, Calvo, BF et al. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: Effective clinical downstaging allows breast preservation and predicts outstanding local control and survival. Ann. Surg. 236(3), 295-302 (2002).
23. Fisher B, Brown A, Mamounas E et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18. J. Clin. Oncol. 15(7), 2483-2493 (1997).
24. Inaji H, Komoike Y, Motomura K et al. Breast-conserving treatment after neoadjuvant chemotherapy in large breast cancer. Breast Cancer 9(1), 20-25 (2002).
25. McIntosh SA, Ogston KN, Payne S et al. Local recurrence in patients with large and locally advanced breast cancer treated with primary chemotherapy. Am. J. Surg. 185(6), 525-531 (2003).
26. Powles TJ, Hickish TF, Makris A et al. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. J. Clin. Oncol. 13(3), 547-552 (1995).
27. Eiermann W, Paepke S, Appfelstaedt J et al. Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study. Ann. Oncol. 12(11), 1527-1532 (2001).
28. Fisher B, Bryant J, Wolmark N et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J. Clin. Oncol. 16(8), 2672-2685 (1998).
29. Dash N, Chafin SH, Johnson RR, Contractor FM. Usefulness of tissue marker clips in patients undergoing neoadjuvant chemotherapy for breast cancer. AJR Am. J. Roentgenol. 173(4), 911-917 (1999).
30. Buchholz TA, Tucker SL, Masullo L et al. Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation. J. Clin. Oncol. 20(1), 17-23 (2002).
31. Fisher ER, Anderson S, Redmond C, Fisher B. Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: Pathological findings from NSABP protocol B-06. Semin. Surg. Oncol. 8(3), 161-166 (1992).
32. Huang E, Buchholz TA, Meric F et al. Classifying local disease recurrences after breast conservation therapy based on location and histology: New primary tumors have more favorable outcomes than true local disease recurrences. Cancer 95(10), 2059-2067 (2002).
33. Smith TE, Lee D, Turner BC, Carter D, Haffty BG. True recurrence vs. new primary ipsilateral breast tumor relapse: An analysis of clinical and pathologic differences and their implications in natural history, prognoses and therapeutic management. Int. J. Radiat. Oncol. Biol. Phys. 48(5), 1281-1289 (2000).
34. Belli P, Pastore G, Romani M, Terribile D, Canade A, Costantini M. Role of magnetic resonance imaging in the diagnosis of recurrence after breast conserving therapy. Rays 27(4), 241-257 (2002).
35. Komoike Y, Motomura K, Inaji H, Kasugai T, Koyama H. Repeat lumpectomy for patients with ipsilateral breast tumor recurrence after breast-conserving surgery. Preliminary results. Oncology 64(1), 1-6 (2003).
36. Kurtz JM, Jacquemier J, Amalric R et al. Is breast conservation after local recurrence feasible? Eur. J. Cancer 27(3), 240-244 (1991).
37. McCready DR, Chapman JA, Hanna WM et al. Factors associated with local breast cancer recurrence after lumpectomy alone: postmenopausal patients. Ann. Surg. Oncol. 7(8), 562-567 (2000).
38. McCready DR, Fish EB, Hiraki GY. Total mastectomy is not always mandatory for the treatment of recurrent breast cancer after lumpectomy alone. Can. J. Surg. 35, 485-488 (1992).
39. Meric F, Mirza NQ, Vlastos G et al. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer 97(4), 926-933 (2003).
40. Vicini FA, Kestin L, Huang R, Martinez A. Does local recurrence affect the rate of distant metastases and survival in patients with early-stage breast carcinoma treated with breast-conserving therapy? Cancer 97(4), 910-919 (2003).
41. Doyle T, Schultz DJ, Peters C, Harris E, Solin LJ. Long-term results of local recurrence after breast conservation treatment for invasive breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 51(1), 74-80 (2001).
42. Moran MS, Haffty BG. Local-regional breast cancer recurrence: prognostic groups based on patterns of failure. Breast J. 8(2), 81-87 (2002).
43. Schmoor C, Sauerbrei W, Bastert G, Schumacher M. Role of isolated locoregional recurrence of breast cancer: Results of four prospective studies. J. Clin. Oncol. 18(8), 1696-1708 (2000).
44. Waeber M, Castiglione-Gertsch M, Dietrich D et al. Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: Definitive results of a Phase III randomized trial (SAKK 23/82) comparing tamoxifen with observation. Ann. Oncol. 14(8), 1215-1221 (2003).
45. Carlson GW, Styblo TM, Lyles RH et al. Local recurrence after skin-sparing mastectomy: Tumor biology or surgical conservatism? Ann. Surg. Oncol. 10(2), 108-112 (2003).
46. Kroll SS, Khoo A, Singletary SE et al. Local recurrence risk after skin-sparing and conventional mastectomy: A 6-year follow-up. Plast. Reconstr. Surg. 104(2), 421-425 (1999).
47. Medina-Franco H, Vasconez LO, Fix RJ et al. Factors associated with local recurrence after skin-sparing mastectomy and immediate breast reconstruction for invasive breast cancer. Ann. Surg. 235(6), 814-819 (2002).
48. Chagpar A, Kuerer HM, Hunt KK, Strom EA, Buchholz TA. Outcome of treatment for breast cancer patients with chest wall recurrence according to initial stage: Implications for post-mastectomy radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 57(1), 128-135 (2003).
49. Wallgren A, Bonetti M, Gelber RD et al. Risk factors for locoregional recurrence among breast cancer patients: Results from International Breast Cancer Study Group Trials I through VII. J. Clin. Oncol. 21(7), 1205-1213 (2003).
50. Katz A, Strom EA, Buchholz TA, Theriault R, Singletary SE, McNeese MD. The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int. J. Radiat. Oncol. Biol. Phys. 50(3), 735-742 (2001).
51. Taylor ME, Haffty BG, Shank BM et al. Postmastectomy radiotherapy. American College of Radiology. ACR Appropriateness Criteria. Radiology 215(Suppl.), 1153-1170 (2000).
52. National Cancer Institute. Adjuvant Therapy for Breast Cancer. NIH Consensus Statement. National Cancer Institute, MD, USA 17(4), 1-35 (2000).
53. Recht A, Edge SB, Solin LJ et al. Postmastectomy radiotherapy: Clinical practice guidelines of the American Society of Clinical Oncology. J. Clin. Oncol. 19(5), 1539-1569 (2001).
54. Overgaard M, Hansen PS, Overgaard J et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Co-operative Group 82b Trial. N. Engl. J. Med. 337(14), 949-955 (1997).
55. Overgaard M, Jensen MB, Overgaard J et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Co-operative Group DBCG 82c randomised trial. Lancet 353(9165), 1641-1648 (1999).
56. Ragaz J, Jackson SM, Le N et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N. Engl. J. Med. 337(14), 956-962 (1997).
57. Cheng JC, Chen CM, Liu MC, Tsou MH, Yang PS, Cheng SH. Locoregional recurrence in patients with one to three positive axillary nodes after mastectomy without adjuvant radiotherapy. J. Formos. Med. Assoc. 99(10), 759-765 (2000).
58. Fodor J, Polgar C, Major T, Nemeth G. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation, the significance of tumor size. Strahlenther. Onkol. 179(3), 197-202 (2003).
59. Chagpar A, Meric-Bernstam F, Hunt KK et al. Chest wall recurrence after mastectomy does not always portend a dismal outcome. Ann. Surg. Oncol. 10(6), 628-634 (2003).
60. Mora EM, Singletary SE, Buzdar AU, Johnston DA. Aggressive therapy for locoregional recurrence after mastectomy in stage II and III breast cancer patients. Ann. Surg. Oncol. 3(2), 162-168 (1996).
61. Dunst J, Steil B, Furch S et al. Prognostic significance of local recurrence in breast cancer after postmastectomy radiotherapy. Strahlenther. Onkol. 177(10), 504-510 (2001).
62. Vandeweyer E, Deraemaecker R. Radiation therapy after immediate breast reconstruction with implants. Plast. Reconstr. Surg. 106(1), 56-58 (2000).
63. Helvie MA, Bailey JE, Roubidoux MA et al. Mammographic screening of TRAM flap breast reconstructions for detection of nonpalpable recurrent cancer. Radiology 224(1), 211-216 (2002).
64. Shaikh N, LaTrenta G, Swistel A, Osborne FM. Detection of recurrent breast cancer after TRAM flap reconstruction. Ann. Plast. Surg. 47(6), 602-607 (2001).
65. Hanks SH, Lyons JA, Crowe J, Lucas A, Yetman RJ. The acute effects of postoperative radiation therapy on the transverse rectus abdominis myocutaneous flap used in immediate breast reconstruction. Int. J. Radiat. Oncol. Biol. Phys. 47(5), 1185-1190 (2000).
66. Tran NV, Chang DW, Gupta A, Kroll SS, Robb GL. Comparison of immediate and delayed free TRAM flap breast reconstruction in patients receiving postmastectomy radiation therapy. Plast. Reconstr. Surg. 108(1), 78-82 (2001).
67. Wright FC, Walker J, Law CH, McCready DR. Outcomes after localized axillary node recurrence in breast cancer. Ann. Surg. Oncol. 10(9), 1054-1058 (2003).
68. Newman LA, Hunt KK, Buchholz T et al. Presentation, management and outcome of axillary recurrence from breast cancer. Am. J. Surg. 180(4), 252-256 (2000).
69. Dixon AK, Wheeler TK, Lomas DJ, Mackenzie R. Computed tomography or magnetic resonance imaging for axillary symptoms following treatment of breast carcinoma? A randomized trial. Clin. Radiol. 48(6), 371-376 (1993).
70. Kronthal AJ, Fishman EK, Gottlieb LM, Davidson NE. CT evaluation of breast cancer: Spectrum of disease. Crit. Rev. Diagn. Imaging 34(3-4), 159-237 (1993).
71. Moskovic E, Curtis S, A'Hern RP, Harmer CL, Parsons C. The role of diagnostic CT scanning of the brachial plexus and axilla in the follow-up of patients with breast cancer. Clin. Oncol. (R. Coll. Radiol.) 4(2), 74-77 (1992).
72. Olliff JF, Cherryman GR. The role of computed tomography in the investigation of recurrent axillary disease in patients with carcinoma of the breast. Clin. Radiol. 41(1), 31-33 (1990).
73. Yong WS, Ng A, Youngson B, Miller N, McCready DR. Potential effects of the new AJCC breast cancer staging system on sentinel lymph node (SLN) positivity and false negative rate. J. Clin. Oncol. 22(Suppl.), 5-18 (2003).
74. Guenther JM, Hansen NM, DiFronzo LA et al. Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. Arch. Surg. 138(1), 52-56 (2003).
75. Millis RR, Springall R, Lee AH, Ryder K, Rytina ER, Fentiman IS. Occult axillary lymph node metastases are of no prognostic significance in breast cancer. Br. J. Cancer 86(3), 396-401 (2002).